Pancreas — Endocrine Function

NCERT grounding

NCERT Class XI Biology, Chapter 19 (§19.2.8 Pancreas) is the syllabus anchor. The chapter opens with the single most testable sentence — "Pancreas is a composite gland which acts as both exocrine and endocrine gland" — and immediately localises the endocrine fraction to the Islets of Langerhans. NCERT quantifies the tissue: there are about 1 to 2 million Islets of Langerhans in a normal human pancreas, representing only 1 to 2 per cent of the pancreatic tissue. Two principal cell types are named — alpha cells secreting glucagon and beta cells secreting insulin. The chapter then describes glucagon as a hyperglycemic peptide hormone acting on hepatocytes through glycogenolysis and gluconeogenesis, and insulin as a peptide hormone that lowers blood glucose by driving cellular uptake and glycogenesis in target cells. The closing paragraph introduces diabetes mellitus — prolonged hyperglycemia, glucosuria and the formation of harmful ketone bodies — treated with insulin therapy.

Heterocrine gland — exocrine and endocrine in one capsule

The pancreas is an elongated, J-shaped retroperitoneal gland that lies behind the stomach, with its head cradled by the duodenal loop and its tail touching the spleen. Within this single capsule live two completely different secretory tissues — and the gland is therefore described as a heterocrine or composite gland. The two tissues differ in cellular architecture, in secretion, in route of delivery and in target.

The exocrine portion dominates 98 to 99 per cent of the gland by mass. It is built of grape-like clusters of serous secretory cells called pancreatic acini, which drain by intercalated, intralobular and interlobular ducts into the main pancreatic duct (duct of Wirsung). The acini synthesise pancreatic juice — a bicarbonate-rich alkaline fluid carrying digestive zymogens (trypsinogen, chymotrypsinogen, procarboxypeptidase) and active enzymes (pancreatic amylase, pancreatic lipase, nucleases). The juice is poured into the duodenum at the hepatopancreatic ampulla. This delivery uses a duct — the diagnostic feature of exocrine glands.

The endocrine portion is the residual 1 to 2 per cent — the Islets of Langerhans, named after Paul Langerhans who first described them in 1869. Each islet is a small, highly vascular cluster of hormone-secreting cells embedded in the acinar sea, with no duct of its own. Islet hormones are released directly into the islet capillaries and ride the portal venous system to the liver — the diagnostic feature of endocrine glands.

Islets of Langerhans — four cell types

NCERT names only two islet cell types explicitly — alpha and beta — but the four-cell classification (alpha, beta, delta, F/PP) is the standard physiology framework and is the format NEET uses for matching-type questions. Each cell type stains differently, occupies a characteristic islet zone, and secretes a single principal hormone.

Insulin — the hypoglycemic peptide

Insulin is a small peptide hormone of 51 amino acids, made of two chains — an A chain of 21 residues and a B chain of 30 residues — held together by two interchain disulfide bridges, with one additional intrachain disulfide loop in the A chain. It is synthesised in beta cells as a single-chain precursor, preproinsulin, processed to proinsulin in the rough endoplasmic reticulum, and finally cleaved in secretory granules to mature insulin plus the C-peptide. The cleavage is the historical reason recombinant human insulin made in E. coli is delivered as separate A and B chains that are reassembled — a fact NEET tests in the biotechnology chapter.

The trigger for insulin release is a rise in blood glucose, principally after a meal. Glucose enters beta cells via GLUT2 transporters, is phosphorylated by glucokinase, and is metabolised — the resulting ATP closes ATP-sensitive K+ channels, depolarises the cell, opens voltage-gated Ca2+ channels, and triggers exocytosis of insulin granules. The principal targets of insulin are hepatocytes and adipocytes, with skeletal muscle added in modern physiology accounts. The receptor is a tyrosine-kinase receptor in the plasma membrane — a peptide-style cell-surface receptor, not an intracellular steroid-style receptor.

The net result, in the words of NCERT, is a rapid movement of glucose from blood to hepatocytes and adipocytes, with consequent fall in blood glucose levels — hypoglycemia. Insulin is therefore called the hypoglycemic hormone.

Glucagon — the hyperglycemic peptide

Glucagon is a single-chain peptide hormone of 29 amino acids, secreted by the alpha cells of the islets. Its principal trigger is a fall in blood glucose, typically during fasting or between meals; sympathetic activity, adrenaline and certain amino acids also stimulate alpha cells. Its principal target is the hepatocyte, on which it acts via a G-protein-coupled receptor and the cAMP second-messenger cascade. The hormone has two main hepatic effects: stimulation of glycogenolysis — the breakdown of stored glycogen to release glucose — and stimulation of gluconeogenesis — the synthesis of fresh glucose from amino acids, lactate and glycerol. Both pour glucose into the bloodstream, producing hyperglycemia.

NCERT also notes that glucagon reduces cellular glucose uptake and utilisation — an effect that compounds the rise in blood glucose. The hormone has minor lipolytic and ketogenic effects in adipose tissue and liver, which become physiologically prominent in starvation and in Type 1 diabetes.

Insulin–glucagon antagonism and the glucose feedback loop

The pancreas is the textbook example of an antagonistic hormone pair regulating a homeostatic variable. Whenever blood glucose drifts from its set-point of roughly 70–110 mg/dL (fasting), the islet senses the deviation and the appropriate cell type fires. The two hormones are not released together — they are released in a reciprocal way that pushes blood glucose back toward the set-point.

The output of the loop is a tightly held plasma glucose — the textbook example of negative feedback. Somatostatin from delta cells acts as a local damper inside the islet, blunting both insulin and glucagon release once their job is done. Pancreatic polypeptide from F cells exerts minor effects on the exocrine pancreas and gall-bladder. NEET 2016 Q.83 explicitly listed insulin–glucagon as an antagonistic pair, alongside parathormone–calcitonin and aldosterone–ANF, distinguishing them from the non-pair relaxin–inhibin.

Diabetes mellitus — when the loop breaks

NCERT describes the clinical consequence of insulin failure in two clean sentences: prolonged hyperglycemia leads to a complex disorder called diabetes mellitus, associated with loss of glucose through urine (glucosuria) and formation of harmful compounds known as ketone bodies; diabetic patients are successfully treated with insulin therapy. NEET 2019 Q.89 and NEET 2020 Q.63 both pair the pancreas with diabetes mellitus in match-list form, and NEET 2024 Q.156 uses glucagon as the foil to confirm it is a peptide, not a steroid.

Modern endocrinology splits diabetes mellitus into two main types — both worth knowing for NEET because the question stems sometimes refer to "insulin-dependent" or "insulin-resistant" forms.

Hyperglycemia drags glucose into the renal filtrate above the tubular reabsorption maximum, so the excess spills into the urine — glucosuria — and drags water with it, producing the classic triad of polyuria, polydipsia and polyphagia. With cells starved of glucose because of absent or ineffective insulin, the body shifts to fat oxidation; massive lipolysis floods the liver with fatty acids that are converted to ketone bodies (acetoacetate, β-hydroxybutyrate, acetone). Their acidity drops blood pH, producing diabetic ketoacidosis — the classical Type 1 emergency.

Worked examples

Common confusion & NEET traps